The question is not whether CGM belongs in your hospital. It is whether you set the standard or follow it.
Trustica serves as the bridge between world-class Yuwell engineering and the frontline of Indonesian medicine. We empower your facility to deliver superior care while optimizing operational efficiency and patient safety.
Diabetes patients in Indonesia
A chronic disease population that is growing annually — representing a sustained and expanding demand for specialist diabetes services.
CGM penetration rate
Despite strong clinical evidence, CGM adoption in Indonesian hospitals remains at an early stage — creating a significant first-mover window for hospital networks ready to lead.
Patients undiagnosed
The undiagnosed population represents a major latent demand for screening, monitoring, and chronic disease programmes that advanced hospitals can capture.
Urban patient base
Urbanizing demographics, rising incomes, and increasing health awareness are expanding the addressable market for premium chronic disease monitoring services.
Your patients are living with diabetes 24 hours a day. Your current services reach them for 30 minutes every 3 months.
Current Standard vs. Advanced Monitoring
Current Standard of Care
✗ Periodic HbA1c testing every 3 months
✗ Finger-prick self-monitoring (1–2×/day)
✗ Consultation-based medication adjustment
✗ No visibility into patient’s daily glucose life
✗ Limited data for proactive clinical decisions
✗ No monitoring between consultations
With TRUSTICA CGM Program
✓ Continuous 24/7 glucose monitoring for every enrolled patient
✓ 7,680 readings across 16 days, fully accessible to the clinical team
✓ Data-driven medication adjustment between consultations
✓ Full visibility into daily lifestyle and glucose patterns
✓ AURTORA™ clinical summaries before each appointment
✓ Continuous remote monitoring and alert capability
Trustica doesn’t sell devices to your hospital. We build your advanced diabetes monitoring program with you.
Hospital decision-makers need to know this won’t create operational disruption, require significant internal IT resources, or burden the clinical team. Show them a clean, structured integration path with Trustica carrying the implementation load.
1
WEEK 1–2: Scoping & agreement
Trustica reviews hospital capacity and patient volume.
2
WEEK 3–4: Clinical setup & staff training
dashboard installation, protocol briefings.
3
WEEK 5–8: Patient pilot
20–50 patients enrolled on First Sight™. AURTORA™ monitors. Clinical team receives GIP™ reports on Day 16.
4
WEEK 9–12: First reports delivered
First GIP™ reports delivered — physician review, outcomes benchmarked.
5
DAY 90: Full programme launch decision
expansion to additional departments
Readings per First Sight™ session
Every session produces 7,680 AURTORA™-analysed data points — versus 32 finger-prick readings in the same period.
complication risk reduction
achievable through consistent early monitoring and clinical intervention enabled by CGM data.
More clinical data
AURTORA™ delivers 3× more actionable clinical data than conventional periodic testing — organised across 7 clinical layers, not raw numbers.
Avg. TIR improvement
Hermina pilot hospitals saw 22% average Time in Range improvement across the first patient cohort.
Advanced CGM monitoring isn’t just better medicine. It’s a better business.
New Service Revenue
CGM program enrollment, sensor fitting fees, specialist monitoring consultations, and expanded follow-up visit frequency all generate incremental revenue within your existing diabetes department.
Patient Retention & Loyalty
Patients enrolled in continuous monitoring programmes have a significantly higher rate of ongoing engagement with the hospital’s specialist team — reducing attrition to other providers and building long-term patient relationships.
Reduced Readmissions
Earlier clinical intervention enabled by CGM data reduces emergency admissions and costly acute complication treatments — improving departmental efficiency and quality metrics simultaneously.
Reputational Leadership
Hospitals offering advanced CGM monitoring programmes are positioned as clinical leaders in diabetes care — attracting high-value patients, specialist talent, and institutional recognition.
Accreditation Support
A structured, outcomes-tracked diabetes monitoring program strengthens documentation of clinical quality standards relevant to hospital accreditation processes.
Research & Data Asset
Your hospital’s Trustica patient cohort generates a longitudinal, de-identified clinical dataset with significant value for diabetes research, publications, and specialist academic development.
The hospitals that lead Indonesia’s diabetes care transformation are the ones starting today.
Begin with a 30-day pilot program. Zero internal IT build. Full Trustica clinical support.
Start Pilot
